https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Seaport%2520Global%2520Transports%2520%2526%2520Industrials%2520Confer....pdf
They are based on management’s expectations that involve a
number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by
the forward-looking statements.
Material
& Color
Expertise
Manufacturing
Expertise
3 to 14 industrial designers
$0 to $7M new business revenue
$4M to $40M opportunities identified
LSS CUSTOMER FIRST
PolyOne Corporation 15
Customer Projects
Cumulative LSS Projects
Enables sales growth by building more intimate
customer relationships, giving us insight to customers’
needs, with a service that is not easily replicated
2 85
PolyOne Corporation 16
W H Y I N V E S T I N P O L Y O N E ?
Segment highlights
COLOR, ADDITIVES & INKS
Color, Additives & Inks
Specialty Engineered Materials
Specialty Engineered Materials
Performance Products & Solutions
Performance Products & Solutions
DISTRIBUTION
Target end markets & �application examples
Slide Number 26
Slide Number 27
Slide Number 28
Slide Number 29
Slide Number 30
Slide Number 31
Slide Number 32
Slide Number 33
Slide Number 34
Slide Number 35
Slide Number 36
Slide Number 37
Investor Presentation - March 2018 r4.pdf
Investor Presentation - March 2018
https://www.avient.com/sites/default/files/resources/Credit%2520Suisse%2520June%252026%25202013.pdf
PolyOne Corporation Investor Day 2012
PolyOne Investor Presentation
Credit Suisse Boston Basic Materials Conference
June 26, 2013
• In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual
results to differ materially from those expressed in or implied by the forward-looking statements.
Average Debt Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Average
PolyOne Debt $ 706.4 $ 705.8 $ 705.2 $ 706.9 $ 1055.5 $ 776.0
Average Equity Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Average
PolyOne shareholders’ equity $ 611.3 $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 669.2
Platform sales and operating income (OI) 2012Y* 2012PF** Q1 2013
Global Specialty Engineered Materials Sales $ 543.6 $ 773.0 $ 159.8
Global Color, Additives and Inks Sales 703.5 828.5 205.3
Designed Structures & Solutions -- 850.6 41.5
Specialty Platform Sales $ 1,247.1 2,452.1 406.6
Performance Products and Solutions Sales 837.0 696.1 159.7
PolyOne Distribution Sales 1,030.3 1,030.3 268.0
Corporate and Eliminations (121.8) (121.6) (33.2)
Total Sales $ 2,992.6 $ 4,056.9 $ 801.1
Global Specialty Engineered Materials OI $ 47.0 $ 47.7 $ 16.2
Global Color, Additives and Inks OI 66.8 81.6 24.1
Designed Structures & Solutions -- 20.9 1.9
Specialty Platform OI $ 113.8 $ 150.2 $ 42.2
Performance Products and Solutions OI 74.9 37.4 13.0
PolyOne Distribution OI 66.0 66.0 16.2
Corporate and eliminations (33.7) (40.0) (14.3)
Special items in OI (53.9) (53.9) (16.6)
Operating income - GAAP $ 167.1 $ 159.7 $ 40.5
Special items in OI 53.9 53.9 16.6
Operating income adjusted $ 221.0 $ 213.6 $ 57.1
Global Specialty Engineered Materials - OI % of
sales
8.6% 6.1% 10.1%
Global Color, Additives and Inks - OI % of sales 9.5% 9.8% 11.7%
Designed Structures & Solutions -- 2.5% 4.6%
Specialty platform OI % of sales 9.1% 6.1% 10.4%
PP&S operating OI % of sales 9.0% 5.4% 8.1%
Distribution OI % of sales 6.4% 6.4% 6.0%
PolyOne OI adjusted, % of sales 7.4% 5.3% 7.1%
PolyOne Investor Presentation�Credit Suisse Boston Basic Materials Conference ��June 26, 2013�
Forward – Looking Statements
Use of Non GAAP Measures
Strategy and Execution Drive Results – Since 2006:
Four Pillar Strategy
2013 Portfolio Transformation Highlights
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Innovation Drives Earnings Growth
We are Experts in Polymer Science and Formulation
Positioned for Strong Growth
First Quarter Financial Highlights
Debt Maturities & Liquidity Summary – 3/31/13
Use of Cash
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2020-09/sustainabilityreport2018.pdf
PolyOne
design team members and material supplier technologists
look for areas where polymers can provide equivalent
performance to traditional materials.
PolyOne has the material science expertise
and regulatory knowledge necessary to help design the
optimum product solution.
Our IQ Design team
contributed design and manufacturing support, and we
donated material to help this incredible organization in
their mission.
https://www.avient.com/sites/default/files/resources/dB%2520June%2520Presentation%2520June%252012%25202013%2520%25282%2529.pdf
PolyOne Corporation Investor Day 2012
PolyOne Investor Presentation
Deutsche Bank 2013 Global Industrials and Basic
Materials Conference
June 12, 2013
• In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual
results to differ materially from those expressed in or implied by the forward-looking statements.
Average Debt Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Average
PolyOne Debt $ 706.4 $ 705.8 $ 705.2 $ 706.9 $ 1055.5 $ 776.0
Average Equity Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Average
PolyOne shareholders’ equity $ 611.3 $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 669.2
Platform sales and operating income (OI) 2012Y* 2012PF** Q1 2013
Global Specialty Engineered Materials Sales $ 543.6 $ 773.0 $ 159.8
Global Color, Additives and Inks Sales 703.5 828.5 205.3
Designed Structures & Solutions -- 850.6 41.5
Specialty Platform Sales $ 1,247.1 2,452.1 406.6
Performance Products and Solutions Sales 837.0 696.1 159.7
PolyOne Distribution Sales 1,030.3 1,030.3 268.0
Corporate and Eliminations (121.8) (121.6) (33.2)
Total Sales $ 2,992.6 $ 4,056.9 $ 801.1
Global Specialty Engineered Materials OI $ 47.0 $ 47.7 $ 16.2
Global Color, Additives and Inks OI 66.8 81.6 24.1
Designed Structures & Solutions -- 20.9 1.9
Specialty Platform OI $ 113.8 $ 150.2 $ 42.2
Performance Products and Solutions OI 74.9 37.4 13.0
PolyOne Distribution OI 66.0 66.0 16.2
Corporate and eliminations (33.7) (40.0) (14.3)
Special items in OI (53.9) (53.9) (16.6)
Operating income - GAAP $ 167.1 $ 159.7 $ 40.5
Special items in OI 53.9 53.9 16.6
Operating income adjusted $ 221.0 $ 213.6 $ 57.1
Global Specialty Engineered Materials - OI % of
sales
8.6% 6.1% 10.1%
Global Color, Additives and Inks - OI % of sales 9.5% 9.8% 11.7%
Designed Structures & Solutions -- 2.5% 4.6%
Specialty platform OI % of sales 9.1% 6.1% 10.4%
PP&S operating OI % of sales 9.0% 5.4% 8.1%
Distribution OI % of sales 6.4% 6.4% 6.0%
PolyOne OI adjusted, % of sales 7.4% 5.3% 7.1%
PolyOne Investor Presentation�Deutsche Bank 2013 Global Industrials and Basic Materials Conference ��June 12, 2013�
Forward – Looking Statements
Use of Non GAAP Measures
Strategy and Execution Drive Results
Four Pillar Strategy
2013 Portfolio Transformation Highlights
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Innovation Drives Earnings Growth
Positioned for Strong Growth
First Quarter Financial Highlights
Debt Maturities & Liquidity Summary – 3/31/13
Use of Cash
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives_Laser Welding Additives for Medical Devices Application Bulletin.pdf
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.
https://www.avient.com/sites/default/files/resources/Gabelli%2520Conf%2520-%2520POL%2520IR%2520Presentation%2520wNon%2520GAAP%2520Reconciliation%252003%252026%252015.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which
could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Platform operating income mix percentage
2005Y* 2008Y* 2010Y* 2013Y 2014Y
Global Color, Additives and Inks $ 4.3 $ 28.1 $ 37.7 $ 104.0 $ 124.9
Global Specialty Engineered Materials 0.4 17.6 49.7 57.2 72.4
Designed Structures and Solutions - - - 33.4 45.1
Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 194.6 $ 242.4
Performance Products and Solutions 75.7 31.3 54.0 56.0 63.1
Distribution 19.5 28.1 42.0 63.3 68.2
Joint ventures 91.9 28.6 18.9 - -
Corporate and eliminations (51.5) (425.1) (27.7) (82.4) (218.6)
Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 231.5 $ 155.1
Less: Corporate operating expense 51.5 425.1 27.7 82.4 218.6
Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 313.9 $ 373.7
Specialty platform operating mix percentage 2% 34% 43% 62% 65%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
Appendix
2014 Financial Highlights
At a Glance�Global Color, Additives and Inks
At a Glance�Global Specialty Engineered Materials
At a Glance�Designed Structures and Solutions
At a Glance�Performance Products and Solutions
At a Glance�Distribution
Plastics: Key to Future Sustainable Development
Commitment to Operational Excellence
A Rich Pipeline of Opportunity
Application Examples
Slide Number 28
Authentication Technology
Range Rover Evoque Interior
Slide Number 31
Metal Replacement Solutions
Next Generation Solar Charger
High-Barrier Packaging Containers
Aerospace Applications
Non-GAAP Reconciliation
Sidoti & Company non-GAAP Rec
https://www.avient.com/sites/default/files/2021-05/avnt-tpe-beginner-guide-fin.pdf
Application design experts can
recommend a TPE based on a general description of the desired product and the
material properties your application requires.
Working
with TPEs also gives you extensive design freedom, customization and color options.
But
here’s a twist—TPEs can also be designed to
absorb water if that is a desired property for
your application.
https://www.avient.com/sites/default/files/resources/PDI_Healthcare_Brochure_2011_0.pdf
PDI) is a complete solutions provider of plastics testing and polymer
consulting within the medical materials and device industries.
Case Study
AxioMed Spine Corporation: Replacement Disc for the Spine
Challenges:
Designers at AxioMed Spine Corp. seized an opportunity to create a revolutionary
replacement disc for the spine using polymer and titanium.
Case Study
AxioMed Spine Corporation: Replacement Disc for the Spine
Challenges:
Designers at AxioMed Spine Corp. seized an opportunity to create a revolutionary
replacement disc for the spine using polymer and titanium.
https://www.avient.com/sites/default/files/2024-03/Global Supplier Quality Manual_2024.pdf
The supplier shall ensure the products are
designed, produced, and tested in conformity with the requirements prescribed by industry
standards or within the supplier’s own QMS.
FDA-designed raw materials shall be produced
according to the requirements specified by the Food, Drug, and Cosmetic Act.
All packaged raw materials shall include the Avient raw material SAP
code number and will not be compromised.
https://www.avient.com/sites/default/files/resources/11.30.18%2520Investor%2520Presentation%2520V1.pdf
They are based on management’s expectations that involve a
number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by
the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the
availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we
conduct business;
• Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
• Fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated
with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to raise or sustain prices for products or services;
• Information systems failures and cyber attacks; and
• Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in
interest rates and changes in the rate of inflation.
Service:�The Timeless differentiator
Talent development
IQ DESIGN LABS
LSS CUSTOMER FIRST
3D Printing�Bringing New ideas to life
Slide Number 34
Innovating with PolyOne
COLOR, ADDITIVES & INKS
Color, Additives & Inks
Specialty Engineered Materials
Specialty Engineered Materials
Performance Products & Solutions
Performance Products & Solutions
DISTRIBUTION
Target end markets & �application examples
Slide Number 44
Slide Number 45
Slide Number 46
Slide Number 47
Slide Number 48
Slide Number 49
Slide Number 50
Slide Number 51
Slide Number 52
Slide Number 53
Slide Number 54
Slide Number 55